Due to tremendous advances in genomic sequencing, clinical metagenomics is poised to revolutionize diagnostics for infectious diseases. The purpose of this symposium was to bring together researchers developing and deploying clinical metagenomic NGS technology to share best practices and the latest technological advances.

By UCLA | Computational Medicine Department

UCLA SwabSeq funded by BARDA to develop “agnostic” virus test.

By Aparna Pillai | Daily Bruin

UCLA researchers are working on a single test that can detect pathogens beyond COVID-19.